Cameron Shearer
Family Medicine · Mount Juliet, TNNPI 1437138641
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.3% of the total across 665 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 38 manufacturers, the largest accounting for just 15.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $3,367 and has fallen 99.1% since, to $31 in 2024. Among family medicine clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 665 payments — averaging $17.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$2K
- GSK$1K
- AstraZeneca$1K
- AbbVie$1K
- Boehringer Ingelheim$689
- Lilly USA, LLC$626
- plus $5K from 32 others
What the payments were for
- Speaking & faculty fees$601%
- Food & beverage$11,31598%
- Education$1401%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 79 | $1,739 |
| GSK | 68 | $1,248 |
| AstraZeneca | 57 | $1,231 |
| AbbVie(2 entities) | 86 | $1,052 |
| Boehringer Ingelheim | 37 | $689 |
| Lilly USA, LLC | 53 | $626 |
| Amarin Pharma, Inc. | 39 | $617 |
| Amgen(2 entities) | 33 | $605 |
| Johnson & Johnson | 26 | $541 |
| Astellas Pharma US Inc | 28 | $538 |
| Novartis | 20 | $270 |
| Pfizer | 16 | $254 |
| Takeda Pharmaceuticals U.S.A., Inc. | 17 | $241 |
| Sanofi-aventis U.S. LLC | 17 | $227 |
| Merck | 15 | $195 |
| Esperion Therapeutics, Inc. | 5 | $195 |
| Eisai Inc. | 12 | $180 |
| Xeris Pharmaceuticals, Inc. | 8 | $179 |
| Arbor Pharmaceuticals, Inc. | 11 | $151 |
| Jazz Pharmaceuticals Inc. | 4 | $82 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $74 |
| Otsuka America Pharmaceutical, Inc. | 4 | $71 |
| Sanofi | 1 | $60 |
| Insulet Corporation | 3 | $47 |
| Biohaven Pharmaceuticals, Inc. | 2 | $45 |
| Kowa Pharmaceuticals America, Inc. | 3 | $44 |
| E.r. Squibb & Sons, L.L.C. | 3 | $41 |
| Hologic Sales And Service, LLC | 2 | $35 |
| Teva Pharmaceuticals USA, Inc. | 2 | $34 |
| Qorumpartners | 1 | $34 |
| Inspire Medical Systems, Inc. | 1 | $31 |
| Lundbeck LLC | 2 | $26 |
| Bausch Health US, LLC | 1 | $25 |
| Lifescan, Inc. | 1 | $24 |
| Bayer | 2 | $24 |
| Qiagen, LLC | 1 | $14 |
| Nalpropion Pharmaceuticals LLC | 1 | $14 |
| Boston Scientific | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$11,515 in reported general payments places this provider in the 95th percentile of 2,087 family medicine providers in Tennessee.
Other family medicine in Mount Juliet
- Bernard PareMount Juliet$22K
- Kevin DennisFranklin$354K
- Charolette JacksonBartlett$162K
- Keren HolmesNashville$58K
- Kabir Harricharan SinghNewport$49K
- Khaisha GistAntioch$49K
- Jerry PunchKnoxville$45K
- Christopher HollowayAntioch$41K
- Curtis JantziKingsport$39K
- Ellen ClelandChattanooga$38K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.